Goodin DS - Search Results

1

A questionnaire to assess neurological impairment in multiple sclerosis.

Goodin DS. Goodin DS. Mult Scler. 1998 Oct;4(5):444-51. doi: 10.1177/135245859800400508. Mult Scler. 1998. PMID: 9839306

2

Survey of multiple sclerosis in northern California. Northern California MS Study Group.

Goodin DS. Goodin DS. Mult Scler. 1999 Apr;5(2):78-88. doi: 10.1177/135245859900500203. Mult Scler. 1999. PMID: 10335515

3

Therapeutic developments in multiple sclerosis.

Goodin DS. Goodin DS. Expert Opin Investig Drugs. 2000 Apr;9(4):655-70. doi: 10.1517/13543784.9.4.655. Expert Opin Investig Drugs. 2000. PMID: 11060700 Review.

4

Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis.

Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA, Glidden D, Weinstock-Guttman B, Reich D, Patterson N, Haines JL, Pericak-Vance M, DeLoa C, Oksenberg JR, Hauser SL. Cree BA, et al. Among authors: goodin ds. Neurology. 2004 Dec 14;63(11):2039-45. doi: 10.1212/01.wnl.0000145762.60562.5d. Neurology. 2004. PMID: 15596747

5

Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?

Goodin DS. Goodin DS. Ann Neurol. 2006 Apr;59(4):597-605. doi: 10.1002/ana.20832. Ann Neurol. 2006. PMID: 16566022 Review.

6

Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis.

Goodin DS, Hurwitz B, Noronha A. Goodin DS, et al. J Int Med Res. 2007 Mar-Apr;35(2):173-87. doi: 10.1177/147323000703500202. J Int Med Res. 2007. PMID: 17542405 Free article.

7

Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.

Goodin DS, Bates D. Goodin DS, et al. Mult Scler. 2009 Oct;15(10):1175-82. doi: 10.1177/1352458509107007. Mult Scler. 2009. PMID: 19737851 Review.

8

Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial.

Goodin DS, Hartung HP, O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Jeffery D, Kappos L, Bogumil T, Knappertz V, Sandbrink R, Beckmann K, White R, Petkau J, Pohl C; BEYOND Study Group. Goodin DS, et al. Mult Scler. 2012 Feb;18(2):181-95. doi: 10.1177/1352458511418629. Epub 2011 Sep 27. Mult Scler. 2012. PMID: 21952094 Clinical Trial.

9

Evidence-based medicine: promise and pitfalls.

Goodin DS, Reder AT. Goodin DS, et al. Mult Scler. 2012 Jul;18(7):947-8. doi: 10.1177/1352458512451660. Mult Scler. 2012. PMID: 22740607 No abstract available.

10

Spinal cord gray matter atrophy correlates with multiple sclerosis disability.

Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, Stern WA, von Büdingen HC, Waubant E, Zhu AH, Goodin DS, Cree BA, Hauser SL, Henry RG. Schlaeger R, et al. Among authors: goodin ds. Ann Neurol. 2014 Oct;76(4):568-80. doi: 10.1002/ana.24241. Epub 2014 Aug 21. Ann Neurol. 2014. PMID: 25087920 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters